Research shows that extra fat tissue around the heart in obese people releases a protein called ANGPTL2 that directly causes heart scarring and irregular heartbeats. According to Gram Research analysis of 2026 findings, ANGPTL2 binds to another protein called SLIT3 and activates two cellular pathways that trigger scarring in heart muscle. Blocking ANGPTL2 in laboratory studies completely prevented this scarring, suggesting it could become a new treatment target for obesity-related heart disease.
Scientists discovered how obesity leads to a dangerous heart condition called atrial fibrillation, where the heart’s upper chambers beat irregularly. According to Gram Research analysis, the problem starts with extra fat tissue that grows around the heart in obese people. This fat releases a protein called ANGPTL2 that triggers a chain reaction, causing the heart muscle to become scarred and stiff. The research, published in 2026, identifies a new target for preventing and treating heart problems related to obesity, offering hope for millions of people struggling with weight-related heart disease.
Key Statistics
A 2026 research article found that obese mice had significantly elevated ANGPTL2 protein levels in heart fat tissue compared to normal-weight mice, and this protein directly caused heart scarring when applied to isolated heart tissue.
Computer modeling revealed that ANGPTL2 binds to SLIT3 with a binding energy of negative 70.66 kilocalories per mole and a confidence score of 0.9925, indicating an exceptionally strong and stable molecular interaction.
When researchers applied antibodies that block ANGPTL2 to heart tissue, the scarring was completely prevented, demonstrating that ANGPTL2 is both necessary and sufficient to cause obesity-related heart damage.
Analysis of human heart tissue from obese patients showed significant activation of the SLIT3/ROBO1 and Wnt5a signaling pathways, confirming that the scarring mechanism discovered in mice also occurs in people.
The Quick Take
- What they studied: How extra fat tissue around the heart in obese people causes scarring and irregular heartbeats
- Who participated: The study used obese mice fed a high-fat diet and isolated heart tissue samples from both mice and human patients
- Key finding: A protein called ANGPTL2 released from heart fat tissue directly causes heart scarring by activating two specific cellular pathways, and blocking this protein prevented the scarring
- What it means for you: This research suggests that targeting ANGPTL2 could become a new treatment to prevent heart rhythm problems in obese people, though human clinical trials are still needed to confirm effectiveness
The Research Details
Researchers used mice that became obese from eating a high-fat diet and compared their hearts to normal-weight mice. They discovered that obese mice had extra fat tissue surrounding their hearts and showed signs of heart scarring. To understand how this happened, scientists took the fat tissue from obese mice and created a liquid extract containing all the proteins the fat releases. When they applied this extract to healthy heart tissue in a laboratory dish, the heart tissue developed scarring, proving the fat tissue was causing the damage.
The team then identified the specific protein responsible: ANGPTL2. When they added pure ANGPTL2 protein to heart tissue, it caused scarring. Importantly, when they added antibodies (immune proteins that block ANGPTL2), the scarring stopped. This proved ANGPTL2 was the culprit. The researchers also studied human heart tissue from obese patients and found the same patterns, suggesting the findings apply to people, not just mice.
Using computer modeling, scientists mapped exactly how ANGPTL2 attaches to another protein called SLIT3 on heart cells. They discovered ANGPTL2 and SLIT3 bind together with remarkable strength, creating multiple connection points. This binding activates two cellular communication pathways that trigger scarring and stiffness in heart muscle.
Understanding the exact mechanism is crucial because it identifies a specific target for new treatments. Rather than trying to treat obesity itself (which is difficult), doctors could potentially block ANGPTL2 or its interaction with SLIT3 to prevent heart damage in obese patients. This approach is like fixing a leak in a pipe rather than trying to empty the entire bathtub.
This research combines multiple rigorous techniques including animal studies, laboratory experiments with isolated tissue, computer modeling of protein interactions, and analysis of human tissue samples. The protein binding was confirmed through three independent methods, making the findings more reliable. However, the study was conducted in mice and laboratory conditions, so results may not perfectly translate to living humans. Clinical trials in people would be needed to develop actual treatments.
What the Results Show
Obese mice developed significant scarring in their left atrium, the upper chamber of the heart that receives blood from the lungs. This scarring is the hallmark of atrial fibrillation, a condition where the heart beats irregularly. The researchers found that obese mice had dramatically higher levels of ANGPTL2 protein in the fat tissue surrounding their hearts compared to normal-weight mice.
When the team applied fat tissue extract from obese mice to healthy heart tissue in a dish, the heart tissue developed scarring within days. This proved the fat tissue was actively causing damage. When they added pure ANGPTL2 protein alone, it produced the same scarring effect. Crucially, when they added antibodies that block ANGPTL2, the scarring was prevented entirely. This demonstrated that ANGPTL2 was both necessary and sufficient to cause the damage.
Computer analysis revealed that ANGPTL2 binds to SLIT3 with exceptional strength, using multiple types of molecular bonds. This binding activated two major cellular pathways: the SLIT3/ROBO1 pathway and the Wnt5a pathway. Both pathways working together triggered the production of scar tissue in heart cells. When researchers examined heart tissue from obese human patients, they found the same pathways were activated, suggesting the mechanism works the same way in people.
The study revealed that ANGPTL2 activates two signaling pathways simultaneously, and both appear necessary for maximum scarring. When only one pathway was blocked, scarring was reduced but not eliminated. This suggests that targeting both pathways together might be more effective than targeting just one. The research also showed that the strength of ANGPTL2 binding to SLIT3 was remarkably high, with a binding energy of negative 70.66 kilocalories per mole, indicating an extremely stable interaction that would be difficult for the body to naturally reverse.
Previous research established that obesity increases the risk of atrial fibrillation, but the exact mechanism was unclear. This study fills that gap by identifying ANGPTL2 as the key messenger protein. Earlier work showed that heart fat tissue is metabolically active and releases harmful substances, but this is the first study to demonstrate that ANGPTL2 specifically drives the scarring process. The finding that ANGPTL2 works through the SLIT3/ROBO1 and Wnt5a pathways is novel and provides new targets that previous research had not identified.
The study was primarily conducted in mice, and while human tissue samples confirmed some findings, full clinical trials in living people have not been performed. The laboratory experiments used isolated heart tissue rather than intact hearts, so the scarring process might work differently in the complex environment of a living organism. The study did not test whether blocking ANGPTL2 would actually prevent atrial fibrillation in obese animals or improve heart function. Additionally, the research did not examine whether the findings apply equally to men and women or to different ethnic groups.
The Bottom Line
Based on this research, people with obesity should work with their doctors to manage weight and monitor heart health, as this study provides a biological explanation for why obesity increases heart rhythm problems. The findings suggest that future treatments targeting ANGPTL2 could help prevent heart damage in obese patients, but such treatments do not yet exist and would require years of development and testing. Current evidence-based recommendations remain weight loss through diet and exercise, regular heart monitoring, and management of other risk factors like high blood pressure and diabetes.
This research is most relevant to obese individuals, especially those with a family history of atrial fibrillation or heart disease. People with existing atrial fibrillation may benefit from understanding why obesity worsens their condition. Cardiologists and obesity specialists should be aware of this mechanism when counseling patients. The findings are less immediately relevant to people at healthy weight, though anyone can develop obesity-related heart problems.
Weight loss typically begins to improve heart function within weeks to months, though significant improvements in heart scarring may take longer. If ANGPTL2-blocking treatments are developed, they would likely need to be taken long-term to prevent scarring progression. The timeline from this basic research discovery to an available treatment is typically 5 to 10 years or longer.
Frequently Asked Questions
Does obesity cause irregular heartbeats and if so how does it happen
Obesity causes irregular heartbeats by triggering heart scarring. Extra fat around the heart releases ANGPTL2 protein, which activates cellular pathways that scar and stiffen heart muscle. This scarring disrupts the electrical signals that control normal heartbeats, leading to atrial fibrillation.
Can blocking ANGPTL2 prevent heart problems in obese people
Laboratory studies show that blocking ANGPTL2 completely prevented heart scarring in isolated tissue. However, human clinical trials have not yet been conducted. If successful in people, ANGPTL2-blocking treatments could become available within 5 to 10 years.
What should obese people do to protect their heart based on this research
Weight loss remains the most proven approach to prevent obesity-related heart damage. Losing even 5 to 10 percent of body weight can improve heart function. Work with your doctor on a weight loss plan combining diet and exercise, and monitor your heart health regularly.
Is this research only relevant to mice or does it apply to humans
The research was conducted in mice, but scientists confirmed the same ANGPTL2 and signaling pathways are active in human heart tissue from obese patients. This suggests the mechanism works similarly in people, though human clinical trials are still needed.
How long does it take for weight loss to improve heart scarring
Heart function improvements from weight loss typically begin within weeks to months. However, reversing existing heart scarring may take longer. Consistent weight loss of 1 to 2 pounds per week provides the best outcomes for heart health.
Want to Apply This Research?
- Track weekly weight and resting heart rate. Note any episodes of heart palpitations or irregular heartbeats. Monitor these metrics alongside diet and exercise logs to identify patterns between weight changes and heart symptoms.
- Set a goal to reduce calorie intake by 500 calories daily and increase physical activity to 150 minutes per week of moderate exercise. Use the app to log meals and workouts, creating accountability for weight loss that directly protects heart health based on this research.
- Establish a baseline resting heart rate and track it weekly. Set a weight loss goal of 1 to 2 pounds per week. If heart palpitations occur, log the date, time, and circumstances. Share this data with your doctor to monitor whether weight loss improves your heart rhythm.
This research describes a biological mechanism discovered in laboratory and animal studies. ANGPTL2-blocking treatments do not yet exist for human use. If you have obesity, atrial fibrillation, or heart palpitations, consult your doctor before making any changes to your treatment plan. Weight loss should be pursued under medical supervision, especially if you have existing heart conditions. This article is for educational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.